Overview

Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154

Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test if the study drug, BXP154 works to stop bleeding from a minor wound in patients that are on anticoagulant therapy. The main questions it aims to answer are: - How long does it take to stop bleeding after BXP154 is applied to a wound? - How many people require the use of a rescue treatment to stop bleeding? - Does BXP154 reduce instances of re-bleeding after the bleeding has stopped initially? - Is BXP154 safe and well-tolerated?
Phase:
Phase 2
Details
Lead Sponsor:
Bio 54, LLC